ArticleBMJ open2021
Cancer in Lahore, Pakistan, 2010-2019: an incidence study.
Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 14 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 1 synthesis or guideline pooled it.
- National cervical cancer burden estimation through systematic review and analysis of publicly available data in Pakistan.BMC public health · 2023Pooled it
- Observational
- Cancer registries in Pakistan: a scoping review.The Lancet regional health. Southeast Asia · 2025Review
- Real‑world data on the outcomes of upfront docetaxel in hormone‑sensitive metastatic prostate cancer.Oncology letters · 2025Article
- Cancer Incidence in Kabul, Afghanistan: The First Report From the Population-Based Cancer Registry.Cancer medicine · 2025Article
- Video based educational intervention in waiting area to improve awareness about health screening among patients visiting family medicine clinics.BMC health services research · 2024Article
- Article
- Impact of SSO-ASTRO Margin Guidelines on Re-excision Rate in Breast-conserving Surgery: A Single-center Experience.Journal of cancer & allied specialties · 2024Article
- Article
- Cancer incidence in Khyber Pakhtunkhwa, Pakistan, 2020.BMC public health · 2023Article
- Cancer in Faisalabad and Nankana Sahib, Pakistan: 2017-2019; An Observational Study.Journal of cancer & allied specialties · 2023Article
- Breast cancer in a teenage girl with BRCA mutation: A case report from a low middle-income country.International journal of surgery case reports · 2022Article
- Cancer Registration in Pakistan: a Reality Check.Journal of cancer & allied specialties · 2022Article
- Knowledge, Attitude and Practice Related to Chemotherapy Among Cancer Patients.Inquiry : a journal of medical care organization, provision and financingArticle
Corrections and comments
- Erratum issued
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesTo study the cancer incidence rates over 10 years (2010-2019), in Lahore, Pakistan.
designAn incidence study.
settingThe population-based Punjab Cancer Registry was established in 2005 in Lahore, which is the provincial metropolis of the province of Punjab (five rivers), and is located in the northeast region of Pakistan. The coordinating office of the Registry is located within Shaukat Khanum Memorial Cancer Hospital and Research Center. Both the active and passive forms of data collection are used.
participantsResidents of the district of Lahore diagnosed with cancer. The average annual population of Lahore was estimated at 11.1 million. OUTCOME MEASURES: Cancer counts and incidence rates per 100 000 population, by age-group, sex and cancer site/type, over 10 years.
resultsIn Lahore, from 2010 to 2019, 58 394 incident cases were reported, with the majority seen in females (57.1%). Adults accounted for 92.2%, adolescents 2.2% and children 5.6% of the total cases. Per 100 000 population, the age-standardised incidence rate was 103.4 for females and 65.6 for males. Among females, the highest incidence rates were recorded for breast cancer (76.7) in adults, bone tumour (1.2) in adolescents and lymphoid leukaemia (1.6) in children, and among males, prostate cancer (10.7) in adults, bone tumour (2.2) in young adults and lymphoid leukaemia (2.4) in children. The age-specific incidence rates peaked in the 60-70 year group, reaching a high of 420 per 100 000 in women and 330 per 1 00 000 men.
conclusionsIn Lahore, the incidence rates for cancers of the breast, prostate, lymphoid leukaemia and bone were among the highest documented. More cases were recorded in females than in males. The results reported could be used as a reference point for assessing the effectiveness of future interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.